Skip to main content

Rebecca Bacon

Assistant Professor in Pathology
Pathology
Department of Pathology, DUMC 3712, Durham, NC 27710
Department of Pathology, DUMC 3712, Durham, NC 27710

Overview


Rebecca Bacon, DVM PhD DACVP

Dr. Bacon earned her DVM from North Carolina State University and completed her veterinary anatomic pathology residency training at Texas A&M University, earning diplomate (DACVP) status in 2022. She earned her PhD in Biomedical Sciences with Texas A&M University in 2024. Her dissertation research investigated chronic enterocolitis in rhesus macaques as a potential model for post-infectious irritable bowel syndrome in humans, and the role Campylobacter sp. plays in the development of these syndromes. This work was supported by an NIH T32 Ruth L Kirschstein National Research Service Award (NRSA) Texas A&M AgriLife Research Institutional Training Grant.

Dr. Bacon maintains a dual appointment as a veterinary pathologist with the Division of Laboratory Animal Resources and as an assistant professor with the Department of Pathology. She provides diagnostic pathology services for the laboratory animal colonies to support individual animal and colony health. She also provides research support to Duke investigators, particularly with regards to development and characterization of animal models of human disease.

Current Appointments & Affiliations


Assistant Professor in Pathology · 2023 - Present Pathology, Clinical Science Departments
Member of the Duke Human Vaccine Institute · 2024 - Present Duke Human Vaccine Institute, Institutes and Centers

Recent Publications


A review of chronic enterocolitis of rhesus macaques (Macaca mulatta) and potential as a naturally occurring model for post-infectious irritable bowel syndrome

Journal Article Frontiers in Veterinary Science · April 1, 2026 Chronic enterocolitis (CE) is a disease of significant concern in colony-housed rhesus macaques, leading to chronic diarrhea and severe weight loss necessitating euthanasia in up to 25% of adults. Despite over three decades of ... Full text Open Access Cite

Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe disease.

Journal Article Mol Genet Metab · March 2026 Systemically administered gene therapy is under development for the treatment of Pompe disease, an inherited lysosomal storage disorder caused by acid alpha-glucosidase (GAA) deficiency. We evaluated recombinant AAV9 vectors expressing GAA driven by the mi ... Full text Link to item Cite
View All Publications

Education


Texas A&M University · 2023 Ph.D.
North Carolina State University · 2015 D.V.M.